The Octopus Value Investing

Public companies research, value investig philosophy and much more.

MiscellaneousMiscellaneous

Sep 28, 2025

#4 Investment Sidebar Snapshots

September 2025 News & Insights Recap

The Octopus Value Investing

Theon InternationalTheon International

Sep 14, 2025

Theon International - Quantitative Analysis

Financials just made my conviction grow bigger

The Octopus Value Investing

MiscellaneousMiscellaneous

Aug 24, 2025

#3 Investment Sidebar Snapshots

Monlunabant, Novo Nordisk & Lesson from 10 Years of US Biosimilars Market

The Octopus Value Investing

PandoraPandora

+1+1

Aug 18, 2025

Pandora A/S - H1 2025 Earnings Review

The Stocks Plunging While the Company is Meeting the FY25 Guidance

The Octopus Value Investing

Novo NordiskNovo Nordisk

Aug 10, 2025

Novo Nordisk - H1 2025 Earnings Review

Lars Fruergaard's Final Earnings as CEO

The Octopus Value Investing

PandoraPandora

Jul 27, 2025

Alexander Lacik, CEO of Pandora, Interview in "Ett Rikare Liv" Podcast

Highlights and Transcripts Translated to English

The Octopus Value Investing

The Octopus PortfolioThe Octopus Portfolio

Jul 20, 2025

#4 The Journey of Compounding - H1 2025 Letter to Readers

Reflections of a Hectic Semester in the Market

The Octopus Value Investing

MiscellaneousMiscellaneous

+1+1

Jul 13, 2025

#2 Investment Sidebar Snapshots

Compiling One Month of Novo Nordisk News & Updates

The Octopus Value Investing

Coloplast A/SColoplast A/S

Jul 06, 2025

Coloplast A/S - Qualitative Analysis

The Danish Intimate Care Powerhouse

The Octopus Value Investing

Sectors in briefSectors in brief

Jun 22, 2025

#6 Sectors in Brief - Medical Devices

Using Compounded Knowledge to Study a Neighboring Sector

The Octopus Value Investing